Compounds and their use for the treatment of alpha1-antitrypsin deficiency
US12365672B2 · kind B2 · utility
0Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 13, 2022 |
| Grant date | Jul 22, 2025 |
| Priority date | — |
| Expiry date | Mar 9, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to specified oxazole compounds of formula (1), and pharmaceutical compositions containing the compounds. The compounds may be inducers of α1-antitrypsin (A1AT), and may be used in the treatment of a disease or disorder such as α1-antitrypsin deficiency (A1AD or AATD).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.